Story perspectives

Stanley Druckenmiller Bets Big on Weight Loss Stocks

11/5/2025

45 6

Summary

Story summary

Stanley Druckenmiller recently sold Nvidia and Palantir shares due to valuations.
He shifted into weight loss drug market, buying 100,675 Eli Lilly and Company shares and 549,295 Viking Therapeutics shares.
Weight loss market is projected to grow from $28 billion to $95 billion by decade's end.
Eli Lilly and Company is generating revenue, while Viking Therapeutics remains in late-stage development.
Investors should weigh their risk tolerance when considering these stocks.

1 of 1

Story summary

Stanley Druckenmiller recently sold Nvidia and Palantir shares due to valuations.
He shifted into weight loss drug market, buying 100,675 Eli Lilly and Company shares and 549,295 Viking Therapeutics shares.
Weight loss market is projected to grow from $28 billion to $95 billion by decade's end.
Eli Lilly and Company is generating revenue, while Viking Therapeutics remains in late-stage development.
Investors should weigh their risk tolerance when considering these stocks.